CIK 0001506492
- Non-accelerated filer
- Smaller reporting company
Nuwellis, Inc.
Sign in to watch- Ticker
- NUWE
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 680533453
- Phone
- +1 952-345-4200
- Business address
- 12988 VALLEY VIEW ROAD, EDEN PRAIRIE, MN, 55344
- Former names
- CHF Solutions, Inc., Sunshine Heart, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 79 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-06-01 | Kridner Debra Exec VP, Regulatory Affairs | Shares withheld for taxes | −557 | $4.38 | $2K | 26,614 |
| 2015-05-21 | WATSON WARREN S Director | Grant or award | +5,439 | 9,628 | ||
| 2015-05-21 | WATSON WARREN S Director | Grant or award · Non-Qualified Stock Option (right to buy) | +3,692 | 3,692 | ||
| 2015-05-21 | WALLER GREGORY D Director | Grant or award | +5,439 | 13,175 | ||
| 2015-05-21 | WALLER GREGORY D Director | Grant or award · Non-Qualified Stock Option (right to buy) | +3,692 | 3,692 | ||
| 2015-05-21 | Salveson Jon W Director | Grant or award | +5,439 | 9,628 | ||
| 2015-05-21 | Salveson Jon W Director | Grant or award · Non-Qualified Stock Option (right to buy) | +3,692 | 3,692 | ||
| 2015-05-21 | ERB JOHN L Director | Grant or award | +5,439 | 9,628 | ||
| 2015-05-21 | ERB JOHN L Director | Grant or award · Non-Qualified Stock Option (right to buy) | +3,692 | 3,692 | ||
| 2015-05-21 | BUCKMAN PAUL Director | Grant or award | +5,439 | 14,012 | ||
| 2015-05-21 | BUCKMAN PAUL Director | Grant or award · Non-Qualified Stock Option (right to buy) | +3,692 | 3,692 | ||
| 2015-05-01 | Wade Molly Vice President | Shares withheld for taxes | −607 | $4.28 | $3K | 14,537 |
| 2015-05-01 | Rosa David A Chief Executive Officer | Shares withheld for taxes | −5,226 | $4.28 | $22K | 135,265 |
| 2015-05-01 | Oleson Kimberly SVP, Clinical Affairs | Shares withheld for taxes | −279 | $4.28 | $1K | 4,089 |
| 2015-05-01 | Kridner Debra Exec VP, Regulatory Affairs | Shares withheld for taxes | −557 | $4.28 | $2K | 27,171 |
| 2015-04-01 | Wade Molly Vice President | Shares withheld for taxes | −607 | $4.26 | $3K | 15,144 |
| 2015-04-01 | Rosa David A Chief Executive Officer | Shares withheld for taxes | −5,226 | $4.26 | $22K | 140,491 |
| 2015-04-01 | Oleson Kimberly SVP, Clinical Affairs | Shares withheld for taxes | −279 | $4.26 | $1K | 4,368 |
| 2015-04-01 | Kridner Debra Exec VP, Regulatory Affairs | Shares withheld for taxes | −557 | $4.26 | $2K | 27,728 |
| 2015-03-01 | Wade Molly Vice President | Shares withheld for taxes | −607 | $5.75 | $3K | 15,751 |
Page 9 of 13 · 242 trades